[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20065765L - Heart and skeletal muscle inflammation (HSMI) virus - Google Patents

Heart and skeletal muscle inflammation (HSMI) virus

Info

Publication number
NO20065765L
NO20065765L NO20065765A NO20065765A NO20065765L NO 20065765 L NO20065765 L NO 20065765L NO 20065765 A NO20065765 A NO 20065765A NO 20065765 A NO20065765 A NO 20065765A NO 20065765 L NO20065765 L NO 20065765L
Authority
NO
Norway
Prior art keywords
skeletal muscle
hsmi
muscle inflammation
virus
heart
Prior art date
Application number
NO20065765A
Other languages
Norwegian (no)
Other versions
NO343278B1 (en
Inventor
Trygve Meum Eliassen
Inge Tom Solbakk
Original Assignee
Pharmaq As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO20042454A external-priority patent/NO20042454D0/en
Application filed by Pharmaq As filed Critical Pharmaq As
Priority to NO20065765A priority Critical patent/NO343278B1/en
Publication of NO20065765L publication Critical patent/NO20065765L/en
Publication of NO343278B1 publication Critical patent/NO343278B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C12N7/08—Inactivation or attenuation by serial passage of virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12061—Methods of inactivation or attenuation
    • C12N2720/12064—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Den foreliggende oppfinnelse angår et isolert hjerte- og skjelettmuskelbetennelsesvirus (HSMIV) utledet fra fisk; et levende, svekket eller inaktivert HSMIV eller deler av det funksjonelt for vaksineformål, et rekombinant antigen eller vaksine; så vel som DNA, cellelinjer, vaksiner, antistoff, fremgangsmater og anvendelser derav. Oppfinnelsen kan anvendes til å forebygge og diagnostisere hjerte- og skjelettmuskelbetennelse (HSMI) hos fisk.The present invention relates to an isolated heart and skeletal muscle inflammation virus (HSMIV) derived from fish; a live, attenuated or inactivated HSMIV or parts of it functional for vaccine purposes, a recombinant antigen or vaccine; as well as DNA, cell lines, vaccines, antibodies, methods and uses thereof. The invention can be used to prevent and diagnose cardiac and skeletal muscle inflammation (HSMI) in fish.

NO20065765A 2004-06-11 2006-12-14 Isolated heart and skeletal muscle inflammation virus (HSMIV), method for producing HSMIV and medical use of HSMIV. NO343278B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO20065765A NO343278B1 (en) 2004-06-11 2006-12-14 Isolated heart and skeletal muscle inflammation virus (HSMIV), method for producing HSMIV and medical use of HSMIV.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NO20042454A NO20042454D0 (en) 2004-06-11 2004-06-11 Novel fish virus
US57882104P 2004-06-14 2004-06-14
PCT/NO2005/000197 WO2005121325A1 (en) 2004-06-11 2005-06-10 Heart and skeletal muscle inflammation (hsmi) virus
NO20065765A NO343278B1 (en) 2004-06-11 2006-12-14 Isolated heart and skeletal muscle inflammation virus (HSMIV), method for producing HSMIV and medical use of HSMIV.

Publications (2)

Publication Number Publication Date
NO20065765L true NO20065765L (en) 2007-01-11
NO343278B1 NO343278B1 (en) 2019-01-14

Family

ID=34993270

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065765A NO343278B1 (en) 2004-06-11 2006-12-14 Isolated heart and skeletal muscle inflammation virus (HSMIV), method for producing HSMIV and medical use of HSMIV.

Country Status (4)

Country Link
CA (1) CA2570050C (en)
GB (1) GB2429711B (en)
NO (1) NO343278B1 (en)
WO (1) WO2005121325A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8562802B1 (en) 2006-02-13 2013-10-22 Life Technologies Corporation Transilluminator base and scanner for imaging fluorescent gels, charging devices and portable electrophoresis systems
CL2008001910A1 (en) * 2007-06-28 2009-08-07 Pharmaq As Fish virus with accession number ecacc 07032902; Cellphone line; vaccine and foods that comprise it; method to isolate and produce the virus, useful to prepare a medicine to prevent and / or treat cardiomyopathy syndrome in fish.
NO20081040L (en) * 2008-02-27 2009-08-28 Thia Medica As Reduced HSMI mortality
WO2011041789A1 (en) * 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus immunogenic compositions
NO2640832T3 (en) * 2010-11-15 2018-05-19
AU2014314140B2 (en) * 2013-08-30 2020-10-22 Pharmaq As Method for propagating a virus
CA3158539A1 (en) 2019-12-16 2021-06-24 Johanna Jacoba Elisabeth Bijlsma Inactivated piscine orthoreovirus vaccine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KONGTORP R.T. ET AL., "Heart and skeletal muscle inflammation in Atlantic salmon, Salmo salar L.: a new infectious disease", Journal of Fish Diseases, vol. 27, nr. 6, 2004, side 351-358, Dated: 01.01.0001 *

Also Published As

Publication number Publication date
NO343278B1 (en) 2019-01-14
WO2005121325A1 (en) 2005-12-22
CA2570050C (en) 2013-03-05
GB2429711B (en) 2008-05-21
CA2570050A1 (en) 2005-12-22
GB0625374D0 (en) 2007-01-31
GB2429711A (en) 2007-03-07

Similar Documents

Publication Publication Date Title
Lycett et al. A brief history of bird flu
Pillet et al. A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults
US11471523B2 (en) Universal vaccines against immunogens of pathogenic organisms that provide organism-specific and cross-group protection
NO20065765L (en) Heart and skeletal muscle inflammation (HSMI) virus
Enjuanes et al. Molecular basis of coronavirus virulence and vaccine development
Begum et al. Challenges and prospects of COVID‐19 vaccine development based on the progress made in SARS and MERS vaccine development
EA201991911A1 (en) METHODS AND COMPOSITIONS FOR TRANSFER OF GENES ON THE VASCULAR NET
NO20054608L (en) Influenza vaccine
HU229101B1 (en) Dna transfection system for the generation of infectious influenza virus
NO20062044L (en) Piscirickettsia salmonis antigens and their use
WO2007047831A3 (en) Functional influenza virus like particles (vlps)
EA201190327A1 (en) NEW CONSTRUCTIONS OF HUMAN PAPILLOMA VIRUS PROTECTION (HPV) AND THEIR APPLICATION IN THE PREVENTION OF DISEASE CAUSED BY HPV
NO20063478L (en) Neutralizing epitope-based growth-promoting vaccine
AR064642A1 (en) POLINUCLEOTIDE VECTOR THAT INCLUDES IT RECOMBINATING CELL THAT UNDERSTANDS THE VECTOR POLYPEPTIDE, ANTIBODY, COMPOSITION THAT UNDERSTANDS THE POLINUCLEOTIDE, VECTOR, RECOMBINATING CELL POLYPEPTIDE OR ANTIBODY, USE OF THE COMPOSITION AND A COMPOSITION AND A METHOD
WO2008039267A3 (en) Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions
NO20090194L (en) Recombinant viral vaccine
WO2008124646A3 (en) Use of amyloid proteins as vaccine scaffolds
WO2010074575A3 (en) Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv.
NO20081043L (en) Vaccine for fish
Dias et al. Antigenic diversity of Brazilian isolates of HoBi-like pestiviruses
Song et al. Sequence-Independent, Single-Primer Amplification Next-Generation Sequencing of Hantaan Virus Cell Culture–Based Isolates
WO2007005627A3 (en) Tuberculosis antigen detection assays and vaccines
Cox et al. Non‐lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication
Nogales et al. Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use
JP2006512078A5 (en)

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 1813 VIKA, 0123 OSLO, NORGE